Ultralife Corporation (NASDAQ:ULBI - Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $6.48 and traded as high as $9.11. Ultralife shares last traded at $8.68, with a volume of 87,966 shares changing hands.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised Ultralife from a "buy" rating to a "strong-buy" rating in a research report on Friday, June 6th.
View Our Latest Stock Report on ULBI
Ultralife Price Performance
The company has a current ratio of 3.22, a quick ratio of 1.70 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $144.35 million, a price-to-earnings ratio of 27.13 and a beta of 1.00. The stock has a 50-day moving average price of $6.62 and a 200 day moving average price of $6.48.
Ultralife (NASDAQ:ULBI - Get Free Report) last posted its earnings results on Friday, May 9th. The technology company reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.15 by ($0.02). Ultralife had a net margin of 3.05% and a return on equity of 4.61%. The business had revenue of $50.75 million for the quarter, compared to analyst estimates of $54.50 million. During the same quarter last year, the business earned $0.21 earnings per share.
Insider Activity at Ultralife
In other Ultralife news, Director Thomas Louis Saeli bought 5,000 shares of the firm's stock in a transaction on Wednesday, May 14th. The shares were acquired at an average cost of $5.44 per share, with a total value of $27,200.00. Following the purchase, the director directly owned 85,000 shares of the company's stock, valued at $462,400. This trade represents a 6.25% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Bradford T. Whitmore bought 11,980 shares of the firm's stock in a transaction on Friday, May 23rd. The stock was acquired at an average cost of $5.41 per share, for a total transaction of $64,811.80. Following the completion of the purchase, the director directly owned 1,060,067 shares in the company, valued at approximately $5,734,962.47. This represents a 1.14% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 47,140 shares of company stock valued at $256,355. 40.00% of the stock is owned by company insiders.
Institutional Trading of Ultralife
Hedge funds and other institutional investors have recently made changes to their positions in the company. IFP Advisors Inc acquired a new stake in Ultralife in the 4th quarter valued at approximately $85,000. Bank of New York Mellon Corp increased its holdings in Ultralife by 35.7% in the fourth quarter. Bank of New York Mellon Corp now owns 43,541 shares of the technology company's stock valued at $324,000 after buying an additional 11,448 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in Ultralife during the 4th quarter worth about $522,000. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Ultralife by 13.2% during the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 178,170 shares of the technology company's stock worth $1,327,000 after buying an additional 20,840 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in Ultralife by 45.3% during the 4th quarter. JPMorgan Chase & Co. now owns 68,952 shares of the technology company's stock worth $514,000 after buying an additional 21,494 shares during the last quarter. Institutional investors and hedge funds own 30.68% of the company's stock.
About Ultralife
(
Get Free Report)
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ultralife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ultralife wasn't on the list.
While Ultralife currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
